J B Nelson
Overview
Explore the profile of J B Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
1258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanjuan M, Nelson J
Behav Processes
. 2019 Jan;
162:1-6.
PMID: 30684733
Exposure to a to-be-tested stimulus produces a reduction in generalization to that stimulus from another similar conditioned stimulus (e.g. Bennett et al., 1994; Symonds and Hall, 1997). Generally, this effect...
2.
Jing Y, Nguyen M, Wang D, Pascal L, Guo W, Xu Y, et al.
Oncogene
. 2017 Oct;
37(5):638-650.
PMID: 28991234
Androgen receptor (AR) activation is critical for prostate cancer (PCa) development and progression, including castration resistance. The nuclear export signal of AR (NES) has an important role in AR intracellular...
3.
Anjanappa M, Hao Y, Simpson E, Bhat-Nakshatri P, Nelson J, Tersey S, et al.
Oncogene
. 2017 Sep;
37(2):185-196.
PMID: 28892047
Tumor complexity and intratumor heterogeneity contribute to subclonal diversity. Despite advances in next-generation sequencing (NGS) and bioinformatics, detecting rare mutations in primary tumors and metastases contributing to subclonal diversity is...
4.
Ai J, Pascal L, Wei L, Zang Y, Zhou Y, Yu X, et al.
Oncogene
. 2016 Oct;
36(15):2054-2065.
PMID: 27721405
Androgens are known to protect prostate cancer cells from DNA damage. Recent studies showed regulation of DNA repair genes by androgen receptor signaling in prostate cancers. ELL-associated factor 2 (EAF2)...
5.
Ai J, Pascal L, OMalley K, Dar J, Isharwal S, Qiao Z, et al.
Oncogene
. 2013 May;
33(18):2286-94.
PMID: 23708662
Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor genes phosphatase and tensin homolog deleted on chromosome 10 (Pten) and androgen upregulated gene 19 (U19), which encodes ELL-associated factor 2...
6.
Miller K, Moul J, Gleave M, Fizazi K, Nelson J, Morris T, et al.
Prostate Cancer Prostatic Dis
. 2013 Feb;
16(2):187-92.
PMID: 23381694
Background: Standard treatment options are limited for the management of non-metastatic castration-resistant prostate cancer (CRPC). This study, part of the ENTHUSE (EndoTHelin A USE) phase III programme, evaluated the efficacy...
7.
Nelson J, TENBROECK C, DAMMIN G
Am J Public Health Nations Health
. 2010 Oct;
35:1282-6.
PMID: 21006721
No abstract available.
8.
9.
10.